[1]
H. Ikram, T. Mahmood Ahmed, A. Hayat, Q. I. kram Ullah, A. Nawaz, and Y. Ikram, “ASSOCIATION OF METABOLIC SYNDROME WITH ATYPICAL ANTIPSYCHOTIC DRUG (OLANZAPINE) SHORT TERM VERSUS LONG TERM USE: Metabolic Syndrome With Atypical Antipsychotic Drug”, PAFMJ, vol. 67, no. 1, pp. 25–30, Oct. 2018.